![Gordon J. Politeski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gordon J. Politeski
Director/Board Member at Novation Pharmaceuticals, Inc.
Profile
Gordon J.
Politeski is currently a Director at Novation Pharmaceuticals, Inc. He was previously the President & Chief Executive Officer at Biomira, Inc. and the President & General Manager at Allergan Pharmaceuticals Ltd., Inc. He also served as a Director at Medwell Capital Corp., Genetronics, Inc., and Pharmacia Canada, Inc. Politeski received his undergraduate degree from the University of Saskatchewan.
Gordon J. Politeski active positions
Companies | Position | Start |
---|---|---|
Novation Pharmaceuticals, Inc.
![]() Novation Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novation Pharmaceuticals, Inc. operates as a biotechnology research and development company. It provides modulation of intracellular messenger RNA (mRNA) to identify new small-molecule therapies to treat serious diseases. The company was founded by Dominique Cheneval and Tania Kastelic and is headquartered in Burnaby, Canada. | Director/Board Member | - |
Former positions of Gordon J. Politeski
Companies | Position | End |
---|---|---|
Biomira, Inc.
![]() Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | President | - |
Genetronics, Inc. | Director/Board Member | - |
Pharmacia Canada, Inc. | Corporate Officer/Principal | - |
Allergan Pharmaceuticals Ltd., Inc.
![]() Allergan Pharmaceuticals Ltd., Inc. Pharmaceuticals: MajorHealth Technology Allergan Pharmaceuticals Ltd., Inc. develops and distributes pharmaceuticals, biologics and medical devices. It imports and exports pharmaceutical products. The company is located in Irvine, CA | President | - |
Medwell Capital Corp.
![]() Medwell Capital Corp. Investment ManagersFinance Medwell Capital Corp. operates as an investment and advisory firm which directly invests in and advises companies on strategy and corporate and technology development. It also provides clinical, regulatory and corporate advisory services. The company was founded on December 15, 1998 and is headquartered in Edmonton, Canada. | Director/Board Member | - |
Training of Gordon J. Politeski
University of Saskatchewan | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 6 |
---|---|
Medwell Capital Corp.
![]() Medwell Capital Corp. Investment ManagersFinance Medwell Capital Corp. operates as an investment and advisory firm which directly invests in and advises companies on strategy and corporate and technology development. It also provides clinical, regulatory and corporate advisory services. The company was founded on December 15, 1998 and is headquartered in Edmonton, Canada. | Finance |
Novation Pharmaceuticals, Inc.
![]() Novation Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novation Pharmaceuticals, Inc. operates as a biotechnology research and development company. It provides modulation of intracellular messenger RNA (mRNA) to identify new small-molecule therapies to treat serious diseases. The company was founded by Dominique Cheneval and Tania Kastelic and is headquartered in Burnaby, Canada. | Health Services |
Pharmacia Canada, Inc. | |
Allergan Pharmaceuticals Ltd., Inc.
![]() Allergan Pharmaceuticals Ltd., Inc. Pharmaceuticals: MajorHealth Technology Allergan Pharmaceuticals Ltd., Inc. develops and distributes pharmaceuticals, biologics and medical devices. It imports and exports pharmaceutical products. The company is located in Irvine, CA | Health Technology |
Genetronics, Inc. | |
Biomira, Inc.
![]() Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | Health Services |
- Stock Market
- Insiders
- Gordon J. Politeski